We earn commissions from the providers listed here. No provider buys a position, a rating, or a listing. The order is set by hand, and we do not claim it is independent of what we earn. Advertising Disclosure

How Online Weight Loss Really Works

Complete guide to online weight loss programs including GLP-1 medications like semaglutide. Learn about virtual consultations, prescription weight loss drugs, coaching support, and realistic results.

Top Weight Loss Providers (2026)

Our Top Choice
1

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
Most Popular
2

First Month $179, Then $299/mo With No Membership Fee

  • Doctor-guided GLP-1 care, 100% online - no waiting rooms
  • Free dietician visits and care coaching included with your plan
  • Doctor-formulated plans adjusted as your body responds
  • Fast, discreet shipping to your door
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
Best Value
3

Wegovy® From $149/mo Plus Membership From $74/mo - Free Insurance Check

  • Full GLP-1 suite: Zepbound®, Wegovy® pill and pen, semaglutide and more
  • Free insurance check shows what your plan covers before you pay
  • Tirzepatide (Zepbound®) averaged up to 20.9% body weight loss in the 72-week SURMOUNT-1 trial; individual results vary
  • On-demand provider coaching and support, 100% online
9.3
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★

About This Comparison

Our Editorial Standards

This weight loss provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, and service areas. Our ratings are editorial judgments, not tallies of reviews.

Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers

Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.

Independent ResearchNo paid placements
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated March 25, 2026
Licensed Providers OnlyAll listed services are US-licensed

Online Weight Loss Programs: How They Work (2026)

Online weight loss programs have transformed obesity treatment by making prescription medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) accessible through telehealth. These programs combine medical supervision, prescription GLP-1 medications, nutritional coaching, and behavioral support to help you achieve sustainable weight loss. Unlike diet apps or meal delivery services, medical weight loss programs involve licensed physicians who prescribe FDA-approved weight management medications. This guide explains exactly how online weight loss programs work, from initial consultation through long-term maintenance, helping you understand if this approach is right for your weight loss goals.

Step 1: Initial Assessment and Consultation

Your weight loss process begins with a complete medical assessment to determine if you qualify for prescription weight loss medication. Programs evaluate your BMI, medical history, previous weight loss attempts, and weight-related health conditions.
  • Eligibility Screening: GLP-1 medications are FDA-approved for adults with BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related condition (diabetes, high blood pressure, high cholesterol, sleep apnea). You must meet these criteria to qualify.
  • Medical History Review: The provider asks about current medications, history of pancreatitis or thyroid cancer, gallbladder disease, diabetic retinopathy, and kidney function. Certain conditions contraindicate GLP-1 use.
  • Weight Loss History: You discuss previous diet attempts, exercise habits, barriers to weight loss, and goals. This helps the provider understand your challenges and set realistic expectations.
  • Metabolic Testing: Some programs include metabolic panels (blood glucose, A1C, lipids, liver and kidney function) to establish baseline health and monitor progress. Testing may be done at local labs or with at-home test kits.
  • Consultation Format: Most programs offer video consultations (20-30 minutes) or detailed questionnaires reviewed by providers within 24-48 hours. Some programs assign you a dedicated physician, while others rotate providers.
  • Program Options: You will choose between medication-only programs ($199-$399/month) or complete programs with coaching, meal plans, and accountability support ($199-$399/month or $1,200-$2,200 annual programs).

Step 2: Prescription and Medication Start

If you qualify, a physician prescribes GLP-1 medication starting at a low dose that gradually increases over 8-20 weeks. The dose escalation minimizes side effects while your body adjusts to the medication.
  • Medication Options: Common prescriptions include semaglutide (weekly injection), tirzepatide (weekly injection), or oral alternatives such as the Wegovy pill and orforglipron, sold as Foundayo, which the FDA approved on April 1, 2026 as a once-daily oral GLP-1. The $900-$1,400/month you see attached to Ozempic, Wegovy, Mounjaro and Zepbound is a retail list price. Bought direct on a self-pay basis as of September 2026, NovoCare lists the Wegovy pill at $149/month, Ozempic at $199 and the Wegovy pen at $199 introductory then $349-$399, and LillyDirect lists Zepbound at $299-$449 with an on-time refill. Compounded versions run $199-$399/month and usually include the visit, where the manufacturer prices cover medication only.
  • Starting Dose: Semaglutide typically starts at 0.25mg weekly for 4 weeks, then increases every 4 weeks (0.5mg, 1mg, 1.7mg, up to 2.4mg maintenance). Tirzepatide starts at 2.5mg weekly and increases to 5mg, 7.5mg, 10mg, up to 15mg maximum.
  • Injection Training: You receive detailed instructions for self-administering subcutaneous injections in your abdomen, thigh, or upper arm. The needles used are short and fine. Video tutorials and customer support are available if the first one feels daunting.
  • Side Effect Management: Common side effects include nausea (20-40% of users), diarrhea, constipation, vomiting, and decreased appetite. These are usually mild and improve as your body adjusts. The provider explains strategies to minimize discomfort.
  • Prescription Timeline: Medication ships within 3-5 days of approval. You start your first dose immediately and follow the escalation schedule provided by your medical team.
  • Cost Considerations: Monthly costs depend on dose (higher doses cost more) and whether you use brand or compounded medication. Budget for 12+ months of treatment as GLP-1s work best with long-term use.

Step 3: Ongoing Support and Lifestyle Coaching

Successful weight loss requires more than medication. complete programs provide nutritional coaching, exercise guidance, behavioral support, and accountability to maximize results and build sustainable habits.
  • Health Coaching: Many programs assign a health coach (nutritionist, nurse, or health educator) for weekly or bi-weekly check-ins. Coaches help with meal planning, exercise routines, and overcoming obstacles.
  • Nutrition Guidance: You receive personalized nutrition plans focused on high-protein, high-fiber meals that complement GLP-1 effects. Programs teach portion control, mindful eating, and how to handle decreased appetite.
  • Exercise Recommendations: Most programs encourage 150+ minutes of moderate exercise weekly (walking, cycling, swimming). Exercise preserves muscle mass during weight loss and improves metabolic health.
  • Behavioral Strategies: Coaching addresses emotional eating, stress management, sleep habits, and building new routines. Sustainable weight loss requires changing behaviors, not just taking medication.
  • Accountability Tools: Programs provide apps for tracking weight, food intake, physical activity, and medication adherence. Regular weigh-ins and progress photos maintain motivation.
  • Community Support: Some programs offer group coaching sessions, online forums, or peer support networks where members share experiences and encouragement.

Step 4: Progress Monitoring and Maintenance

Regular monitoring ensures the medication is working safely and effectively. Providers track weight loss, adjust dosages, manage side effects, and plan for long-term weight maintenance.
  • Monthly Check-ins: Providers review your weight loss progress, side effects, and medication tolerance. For context on what the medications did in trials rather than a prediction for you, the STEP 1 and SURMOUNT-1 averages are cited in the FAQ below, and individual results vary widely.
  • Dose Adjustments: If you are not losing weight adequately (less than 5% after 12-16 weeks), the provider may increase your dose faster. If side effects are severe, doses may be reduced or held steady longer.
  • Lab Monitoring: Repeat metabolic panels every 3-6 months check blood sugar, lipids, liver and kidney function. These tests ensure the medication is safe and track improvements in metabolic health.
  • Plateau Management: Weight loss often plateaus after 6-12 months. Providers help by adjusting medication doses, reviewing diet and exercise habits, or adding complementary strategies.
  • Maintenance Phase: Once you reach your goal weight, you transition to a maintenance dose (often lower than maximum) to prevent weight regain. Most patients continue medication indefinitely as stopping leads to weight regain.
  • Long-term Planning: Programs help you develop sustainable habits so you can maintain weight loss. Some patients eventually taper off medication, though most continue long-term for best results.

Online vs In-Person Treatment Comparison

Understanding the differences between online and in-person treatment helps you choose the right approach for your needs.

FeatureOnline ProgramsIn-Person Programs
Consultation Time20-30 minutes video or submit questionnaire anytime60-90 minutes including travel and wait time
Medication OptionsCompounded semaglutide/tirzepatide ($199-$399/month, visit usually included); brand direct from the manufacturer on self-pay, $149-$449/month depending on product and dose (Sept 2026, medication only)Brand Ozempic/Wegovy/Mounjaro at the pharmacy counter, $900-$1,400/month retail list price with Rx
Coaching SupportVirtual health coaches, messaging support, app-based trackingIn-person sessions with dietitians and exercise specialists
Appointment Availability24/7 messaging, flexible video call schedulingLimited office hours, must schedule weeks in advance
Monthly Cost$199-$399/month (medication + coaching)$300-$800/month (visits + brand medication + lab work)
Medication DeliveryShipped to your door monthly with auto-refillsPharmacy pickup (if covered) or in-office dispensing
Lab WorkLocal lab orders or at-home test kitsIn-office phlebotomy or lab referrals
PrivacyComplete from home, discreet deliveryRequires office visits, potential for public weight tracking
Insurance CoverageRarely covered, mostly cash-payMay be covered if medically necessary (varies widely)
Best ForCost-conscious, prefer convenience, comfortable with telemedicinePrefer face-to-face care, insurance covers program, complex needs

Frequently Asked Questions

How much weight can I expect to lose with online weight loss programs?

The trial numbers give you the clearest picture. In the STEP 1 trial, published in the New England Journal of Medicine in 2021, adults on semaglutide 2.4mg lost an average of 14.9% of body weight over 68 weeks. In SURMOUNT-1, adults on tirzepatide 15mg lost an average of 20.9% over 72 weeks. Those are averages from trial populations, and individual results vary considerably with starting weight, adherence, and how your body responds. What any of it means for you is a conversation with a licensed provider.

Are GLP-1 medications safe for weight loss?

Yes, when prescribed appropriately and monitored by healthcare providers. Semaglutide and tirzepatide are FDA-approved for weight loss and have been extensively studied. Common side effects (nausea, diarrhea) are usually mild. Rare serious risks include pancreatitis, gallbladder disease, and thyroid tumors (seen in animal studies, not confirmed in humans). Your provider screens for contraindications before prescribing.

What happens if I stop taking weight loss medication?

Most people regain 50-100% of lost weight within 12 months of stopping GLP-1 medications. These drugs do not cure obesity, they treat it while you use them. For lasting results, most people continue medication long-term at a maintenance dose. Some programs help you transition to lower doses or develop habits to maintain weight without medication, but success rates are lower.

Do I need to diet and exercise while taking weight loss medication?

Yes. GLP-1 medications work best when combined with healthier eating and regular physical activity. The medications reduce appetite and help you feel full with less food, but you still need to make good food choices. Exercise preserves muscle mass during weight loss and improves metabolic health. Programs that combine medication with coaching produce better long-term results than medication alone.

How much do online weight loss programs cost?

Monthly costs range from $199-$399 for compounded GLP-1 medications plus coaching. Annual programs like Calibrate cost $1,200-$2,200 total. The $900-$1,400/month figure attached to brand-name Ozempic and Wegovy is a retail list price rather than what a cash-pay buyer now pays: as of September 2026 NovoCare lists the Wegovy pill at $149/month, Ozempic at $199 and the Wegovy pen at $199 introductory then $349-$399, and LillyDirect lists Zepbound at $299-$449 with an on-time refill, all medication-only prices that assume you already hold a prescription. Most insurance plans still do not cover weight loss treatment, so compare the flat telehealth fee against the manufacturer self-pay price for your specific dose rather than against the list price.

Can I use my insurance for online weight loss programs?

Most online weight loss programs do not accept insurance and operate on a cash-pay basis. However, some insurance plans cover GLP-1 medications when prescribed for obesity (BMI over 30 or 27 with comorbidities). You can try getting brand-name prescriptions covered through your insurance, though prior authorization is often required and many plans exclude weight loss drugs. HSA/FSA funds typically cover medically supervised weight loss programs.

What is the difference between semaglutide and tirzepatide?

Both are weekly injections that act on appetite signalling. Semaglutide (Ozempic, Wegovy) is a GLP-1 agonist; tirzepatide (Mounjaro, Zepbound) is a dual GIP and GLP-1 agonist. In the head-to-head SURMOUNT-5 trial, tirzepatide participants lost an average of 20.2% of body weight versus 13.7% on semaglutide at 72 weeks (individual results vary). Both carry gastrointestinal side effects, nausea above all. Cost, coverage, and how you personally respond usually decide it, which makes this a provider conversation.

Do I qualify for prescription weight loss medication?

You qualify if you are an adult with BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related health condition (diabetes, high blood pressure, high cholesterol, sleep apnea). You must not have contraindications like history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, or severe pancreatitis. Your provider will determine eligibility during consultation.

How long do I need to take weight loss medication?

Most people take GLP-1 medications long-term (12+ months to years) to maintain weight loss. The STEP 1 extension study reported weight regain after the medication is stopped. Think of obesity as a chronic condition requiring ongoing treatment, similar to high blood pressure or diabetes. Some people successfully transition to lower maintenance doses after reaching goal weight, reducing monthly costs while preventing regain.

What if I have side effects from weight loss medication?

Nausea, diarrhea, and constipation are common initially but usually improve within 2-4 weeks as your body adjusts. Strategies include eating smaller meals, avoiding fatty foods, staying hydrated, and taking the medication at a consistent time. If side effects are severe, your provider can slow dose escalation, reduce your dose, or switch medications. Most people tolerate GLP-1s well once they adjust.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.

Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

Start With a Top Weight Loss Provider

Our Top Choice
1

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
Most Popular
2

First Month $179, Then $299/mo With No Membership Fee

  • Doctor-guided GLP-1 care, 100% online - no waiting rooms
  • Free dietician visits and care coaching included with your plan
  • Doctor-formulated plans adjusted as your body responds
  • Fast, discreet shipping to your door
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
Best Value
3

Wegovy® From $149/mo Plus Membership From $74/mo - Free Insurance Check

  • Full GLP-1 suite: Zepbound®, Wegovy® pill and pen, semaglutide and more
  • Free insurance check shows what your plan covers before you pay
  • Tirzepatide (Zepbound®) averaged up to 20.9% body weight loss in the 72-week SURMOUNT-1 trial; individual results vary
  • On-demand provider coaching and support, 100% online
9.3
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★

Ready to Compare Providers?

Now that you understand how online treatment works, compare providers to find the best option for your needs and budget.

Medical Disclaimer: This guide is for informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any treatment. Individual results and experiences may vary. Read our full medical disclaimer.

Regulatory noticeRegulatory note (verified August 22, 2026): On February 20, 2026 the FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455) citing misbranding under sections 502(a) and 502(bb) of the FD&C Act. Reviewing medvi.io in December 2025, the FDA said labels bearing "MEDVi" implied MEDVi compounds the drugs when it does not, and that "Same active ingredient as Wegovy and Ozempic" and "Same active ingredient as Mounjaro and Zepbound" implied an FDA approval compounded drugs do not have. We found no close-out letter, so the matter appears open. MEDVi states medvi.io is affiliate-operated rather than company-operated; we could not verify that, and the letter is addressed to MEDVi, LLC. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): The FDA reviewed struthealth.com in December 2025 and, on February 20, 2026, issued Strut Health, LLC a warning letter, MARCS-CMS 721448. It raises two separate problems. Pictured product labels carry the "Strut" name, which the agency said represents Strut as the compounder of the semaglutide and tirzepatide products when it is not. Three site claims are also quoted, among them "Generic Zepbound, Mounjaro" and "Semaglutide is the active ingredient in the brand medications." Because compounded drugs hold no FDA approval, the FDA said wording of that kind implies one, and it cited misbranding under sections 502(a) and 502(bb) of the FD&C Act. FDA’s warning letter index shows no response letter and no close-out letter, so we treat the matter as open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Eden Health International Inc. was sent FDA warning letter MARCS-CMS 728279 on June 8, 2026, following an agency review of tryeden.com in March 2026. The letter lists two findings. The first is the "Eden" name on pictured labels for compounded semaglutide and tirzepatide, which the FDA said represents Eden as the compounder when it is not. The second is the site’s description of its sourcing as "FDA-licensed 503(a) outsourcing facilities," a designation the agency says does not exist, because the FD&C Act creates no FDA approval or license for pharmacies or outsourcing facilities. Both were cited as misbranding under sections 502(a) and 502(bb). FDA has posted no close-out letter, so the matter reads as open. Read the FDA letter

Verification limitationVerification note (checked August 23, 2026): we could not identify the legal entity behind HealthRx through public records. Its website does not name an operating company, its domain registration is privacy-shielded, and we could not confirm a listing in any business registry or accreditation database we checked. This is not a finding of wrongdoing. It means our usual checks, including our search of FDA enforcement records, could only be run against the brand name and domain rather than a confirmed company.

Regulatory noticeRegulatory note (verified August 22, 2026): One sentence is all that FDA warning letter MARCS-CMS 715879 quotes. Sent to Sprout Health Partners LLC on September 9, 2025 after an August 2025 review of joinsprouthealth.com, it cites the line "GLP-1 medications are FDA-approved and backed by extensive clinical research..." Appearing on pages offering compounded semaglutide and tirzepatide, that statement implied to the agency that the compounded products themselves are FDA-approved, which they are not, and it was cited as misbranding under FD&C Act 502(a) and 502(bb). A search of FDA’s warning letter index turns up no close-out letter, so the matter appears open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Skinny.Rx operates as SkinnyRx, but the legal entity is Lean Rx, Inc., and that is the name on FDA warning letter MARCS-CMS 717989, dated February 20, 2026. Following a December 2025 review of skinnyrx.com, the agency objected to the "SkinnyRx" name on pictured labels, saying it implies SkinnyRx compounds the drugs itself, and to three marketing lines, including "Get access to the same active ingredient as name-brand GLP-1 medications" and "It contains the same active ingredient as FDA-approved medications." Compounded semaglutide and tirzepatide are not FDA-approved, so the FDA read those lines as implying an approval that does not exist and classed the products as misbranded. No close-out letter is posted; read the matter as unresolved. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Hers is a brand of Hims & Hers Health, Inc., and the FDA wrote to that company twice on September 9, 2025, once for each brand. The Hers letter, MARCS-CMS 716825, went to chief executive Andrew Dudum after an August 2025 review of forhers.com. It quotes two claims made for compounded semaglutide: "Weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." The agency’s position is that compounded products carry no FDA approval, so claims like these imply a sameness with approved medicines that has not been established, making the products misbranded. FDA’s index lists neither a response nor a close-out letter, so the matter stands open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): On September 9, 2025 the FDA sent Hims & Hers Health, Inc. a warning letter covering the Hims brand, MARCS-CMS 716567, drawn from a review of hims.com the previous month. Two lines about compounded semaglutide are quoted in it: "Same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." Compounded drug products are not FDA-approved, and the agency said phrasing of this sort suggests otherwise, which is what makes the products misbranded under FD&C Act sections 502(a) and 502(bb). A companion letter went to the same company that day for its Hers brand. No close-out letter appears in FDA’s index; treat this as open. Read the FDA letter